Navigation Links
Zeus to Present at Digestive Disease Week in Chicago

Zeus Research & Development will be one of the presenters at Digestive Disease Week, addressing the topic of invention of new devices in interventional gastroenterology

ORANGEBURG, S.C., May 29 /PRNewswire/ -- Zeus, Inc., a leader in polymer extrusions and material science, announces it has been invited to present at Digestive Disease Week in Chicago on June 1, 2009. Zeus presenters Dr. Bruce Anneaux, Ph.D. and GI Endoscopy Specialist Aubrey Sanders will address possible polymer selection for building new and innovative medical devices for interventional procedures in gastrointestinal endoscopy and Natural Orifice Translumenal Endoscopic Surgery (NOTES).

Digestive Disease Week is the world's largest meeting of researchers, physicians, and other professionals in the fields of gastroenterology, endoscopy, gastrointestinal surgery, and hepatology.

When Dr. Naomi Nakao, a prolific inventor of 20 years extended her invitation to Zeus to speak at the conference, she prefaced her invitation as follows: "Being an inventor can be a lonely journey, but Zeus has faithfully stood by me for these many years. Zeus engineers have generously helped me during my research and development of the many prototypes of my inventions. I was gently brought down to earth by Zeus engineers, learning what is, and is not, possible in building my devices. Sharing their company's varied capabilities, I learned from Zeus' engineers that things I did not think possible could be built because of the enormous imagination that Zeus puts into its colossal ensemble of shapes, forms, colors, and sizes of the catheters and other sub-components that it has to offer."

The Zeus presentation will focus primarily on developing industry advancements in polymer science with an emphasis on gastroenterology and endoscopy of the present and future. At the conclusion of the presentation, Dr. Anneaux and Ms. Sanders will participate in an open panel discussion.

Commenting on his presentation Dr. Bruce Anneaux, Corporate Manager, Research & Development for Zeus, said, "We are excited about the opportunity to present at a gathering of this scope and significance. Both the Zeus presentation and open panel discussion seek to enhance attendees' understanding of polymer selection and create an open dialogue among the innovators in gastroenterology/endoscopy medical device industry."

Bob Jennings, Vice President for Medical Sales and Marketing, said, "Zeus has an evolving history of exploring and advancing innovative concepts and processes in the medical device industry. It is this commitment that allows us to serve as a resource for inventors, physicians, and other professionals who strive to enhance medical applications and ultimately, improve patient care."

About Zeus, Inc.:

Zeus, Inc. is headquartered in Orangeburg, SC, USA. Zeus is a world leader in material science and the development of high-performance polymer tubing used in demanding applications, operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling, and mechanical markets. For more information, visit

    Press Contact:

    Samantha D. Farlow
    Zeus, Inc.
    Communications Coordinator
    (803) 268-9505

This release was issued through eReleases(TM). For more information, visit

SOURCE Zeus, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Oral VDA CYT997 - Phase I Clinical Trial Presentation at ASCO
3. Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
4. Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting
5. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
6. Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions
7. Clinical Data on Peregrines Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting
8. Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
9. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
10. POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009
11. InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR 09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le
Post Your Comments:
(Date:11/27/2015)... 27, 2015 ... of companion diagnostics is one of the ... with pharmaceutical companies and diagnostic manufacturers working ... . --> ... on global cancer biomarkers market spread across ...
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... of Black Aerospace Professionals (OPBAP) has been formalized with the signing of a ... leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, ...
(Date:11/24/2015)... ... , ... The United States Golf Association (USGA) today announced Dr. Bruce Clarke, ... annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished service to ... Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in the department ...
Breaking Biology Technology:
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):